VIYASH SCIENTIFIC LIMITED Valuation
VIYASH · Healthcare · Current price ₹258.5
Is VIYASH SCIENTIFIC LIMITED undervalued?
DocStoX estimates the fair value of VIYASH SCIENTIFIC LIMITED at ₹135 per share, versus the current market price of ₹259. That puts the stock about -47.9% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹66), Relative P/E (₹159), Graham floor (₹78), Analyst target (₹321). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹66 (bear) to ₹135 (base) to ₹321 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
VIYASH SCIENTIFIC LIMITED trades at a P/E of 63.7x and a P/B of 4.4x, with a dividend yield of 0.2%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on VIYASH SCIENTIFIC LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.